Repare Therapeutics Inc Stock - RPTX Share Price Today, News and Discussion

Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

152

Current Price	$12.60
Prev Close	$12.36
Open	$12.36
Dividend Yield	0.00%
50-Day Moving Average	$14.51
Beta	1.12
Avg. Volume	142,001.35
PE Ratio	N/A

52-Week High	$18.68
52-Week Low	$8.07
Market Capitalization	$528.71M
EPS	-$0.7356
Price to Book	1.73
Revenue Per Employee	$792,822.37
Enterprise Value/EBITDA	-7.23

No RPTX news at the moment.

RPTX Repare Therapeutics Inc

About

Feed

Fundamentals

News